HEALTH RELATED QUALITY OF LIFE IN THE DIFFERENT STAGES OF COLORECTAL CANCER IN PATIENTS ATTENDED IN THE SOCIAL SECURITY MEXICAN INSTITUTE

Author(s)

Iris Contreras-Hernandez, MSc, MD, Health Economics Researcher1, Luz-Ma-Adriana Balderas-Peña, PhD, Clinical Researcher2, Jf Mould-Quevedo, PhD, MSc, MBA, Pharmacoeconomics Manager3, Juan Garduño-Espinosa, PhD, MD, Health Economics Researcher1, Gilberto Morgan-Villela, MD, Chief of Oncology Division41Social Security Mexican Institute, Mexico City, Mexico; 2 Social Security Mexican Institute, pecialties' Hospital. Western National Medical Center, Guadalajara, Mexico; 3 Pfizer Mexico, Mexico City, Mexico; 4 Social Security Mexican Institute, Guadalajara, Mexico

OBJECTIVES The aim of this study was to describe health related quality of life in different stages of colorectal cancer in patients attended in a tertiary referral center at the Social Security Mexican Institute METHODS Were included outpatients with colorectal cancer, attended in a tertiary referral center since July to August 2008, with the following inclusion criteria: older than 16 years, colorectal cancer histological diagnosis, accepted were included through informed consent; were excluded patients with second malignant neoplasm or incomplete information. To calculate health related quality of life EORTC QLQ-C30 score validated Spanish version to México was used; were evaluated global health status, functional scales (physical, role, emotional, cognitive, social) and symptom scales (fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite loss, constipation, diarrhea, financial difficulties) in scale since 0 to 100 (0=death, 100=perfect health). Were calculated means and range for EORTC QLQ-C30 score items; statistical differences were calculated through ANOVA test, p value <0.05 was considered significant RESULTS We studied 31 colorectal cancer patients, mean age patients was 55±11.5 years old, 54% were women, 71% were married, and 38% had secondary school. The stating of this group was distributed as follow: II-4 (13%), III-2 (6%) IV-7 (23%) and NC (non-classified)-18 (58%) (without complete histopathology report). Health related quality of life mean according stage for all items was: II:57±22, III:86±12 and IV:66±14 NC 76±19 (p= 0.17) The assumptions associated with a decreased health related quality of life associated with disease progression were pain (II-20, III-75, IV-52;p=0.02) and financial problems (II-25, III-100, IV-76;p=0.09. CONCLUSIONS We observed a decreased health related quality of life associated with late clinical stage by pain and financial problems.

Conference/Value in Health Info

2009-05, ISPOR 2009, Orlando, FL, USA

Value in Health, Vol. 12, No. 3 (May 2009)

Code

PCN81

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×